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Improving Target LDL-C Levels in Diabetic Patients Using the Electronic Health Record: 
A Primary Care Practice Improvement Project  
 
Abstract 
 
Background and Purpose: This evidence-based project conducted a practice change in a 
primary care setting to improve provider adherence in monitoring, treating and documenting 
LDL-C management for adults with type 2 diabetes.   
 
Methods: The project was conducted over 8 weeks. A clinical support tool, the Diabetic LDL 
Protocol, was developed for the clinic to implement into practice. The providers were instructed 
to use the tool during each encounter with an adult diabetic patient. Pre- and post-
implementation data were abstracted from the electronic health records of 41 patients with type 2 
diabetes during the implementation period.  
 
Conclusions: The providers’ adherence rate for use of the Diabetic LDL Protocol peaked at 6 
weeks post-implementation and declined steadily by 8 weeks. The tool was only used during 
29% of the applicable patient visits. Communication issues during implementation of the 
protocol and electronic health record system restrictions were contributing factors to poor 
adherence.  
 
Implications for Practice: The use of a clinical support tool may promote adherence to 
guidelines for diabetic patients in primary care. Integrating the tool into the workflow of a 
primary care practice and encouraging use of the tool are the major challenges of successful 
implementation. Further research is necessary to investigate strategies that can overcome clinical 
inertia and increase provider willingness to comply with new electronic protocols.  
 
Introduction to the Problem 
 Diabetic patients have an increased risk for cardiovascular disease, with a mortality rate 
from cardiac disease two to four times higher than individuals without diabetes (Nesto, 2008; 
Sperl-Hillen et al., 2010). The management of low-density lipoprotein cholesterol (LDL-C) in 
diabetic patients is a critical component in decreasing cardiovascular disease and mortality for 
this high-risk population (Nesto, 2008; Sperl-Hillen et al., 2010). In general, primary care 
providers are not meeting national standards for target LDL-C levels for their diabetic patients 
(Casagrande, Fradkin Saydah, Rust, & Cowie, 2013; Davidson, 2009; Nesto, 2008; Sperl-Hillen 
et al., 2010 ).  
 Strong evidence indicates that a reduction in LDL-C level results in a proportionate 
reduction in cardiovascular disease and mortality (Cholesterol Treatment Trialists & 
Collaborators, 2005, 2008; Shepherd et al., 2006). Studies have estimated that each 1.8mg/dL 
decrease in LDL-C level reduces the risk of a cardiovascular event by 1% (Katcher, Hill, 
Lanford, Yoo, & Kris-Etherton, 2009). Primary care providers have a variety of treatment 
options to assist with LDL-C reduction, including prescribing medications, offering dietary 
recommendations, and encouraging healthy lifestyle changes (Katcher et al., 2009; National 
Institute of Health, 2002). Unfortunately, in a busy practice setting, the opportunity to address 
LDL-C levels is often missed. 
Prior Research on Diabetic Clinical Support Tools 
 LDL-C guidelines have existed for years, yet clinicians still have difficulty meeting these 
goals for their patients (Sperl-Hillen et al., 2010). Common healthcare specific reasons cited as 
barriers to implementation of these guidelines are clinician inertia and outdated paper patient 
health records; clinical inertia refers to the failure of a provider to intensify a therapy when a 
patient is not meeting clinical goals (Sperl-Hillen et al., 2010). Transitioning from a paper chart 
system to an electronic health record (EHR) has been associated with improved glycemic and 
cholesterol control for diabetic patients (Cebul, Love, Jain, & Hebert, 2011; Reed et al, 2012). 
However, simply implementing the EHR may not be enough to make needed changes. The tools 
and decision support that are imbedded in the EHR likely make the biggest impact in clinician 
behavior and patient outcomes (Bell et al., 2010; Cebul et al., 2011; O’Connor et al., 2011; 
Roshanov et al., 2011; Samal, Linder, Lipsitz, & Hicks, 2011; Sperl-Hillen et al., 2010; Weber, 
Bloom, Pierdon, & Wood, 2007). 
 With advances in technology, one common solution is the use of the diabetic clinical 
support tools integrated into the EHR (Cebul et al., 2011; Reed et al., 2012; Sperl-Hillen, et al., 
2010 ). The use of these support tools has demonstrated successful improvements in the use of 
guidelines in primary care settings (Bell et al., 2010). Furthermore, the use of diabetic clinical 
support tools has demonstrated increased test rates for intermediate outcomes for diabetic 
patients including Hemoglobin A1c, LDL-C levels, and blood pressure (O’Connor et al., 2011; 
Reed et al., 2012; Roshanov et al., 2011; Samal et al., 2011; Sperl-Hillen et al., 2010; Weber et 
al., 2007.  
 The problem lies in the actual improvement of these values. Past studies indicated that 
most clinical support tools merely improve monitoring of these outcomes and do not lead to 
improved patient outcomes (Sperl-Hillen et al., 2010). Therefore, if the goal is to meet national 
guidelines for a given outcome, the practice change must not only encourage a provider to obtain 
lab values or perform testing but also to implement an appropriate intervention. According to 
Sperl-Hillen et al. (2010), the most successful diabetic support tools overcome clinical inertia 
and encourage the provider to prescribe more aggressive pharmacological and lifestyle 
interventions. 
 In a study by Sperl-Hillen et al. (2010), the Diabetes Wizard EHR clinical decision 
support tool was implemented as a randomized trial that included 41 primary care providers and 
2556 diabetic patients at 11 primary care clinics. Six clinics were randomly chosen to implement 
the tool, while the other clinics served as controls. The intent of the intervention was to change 
provider behavior through the use of clinical support tools to ultimately improve HbA1c, blood 
pressure, and LDL-C levels in type 2 diabetics. Results showed that the intervention group used 
the Diabetes Wizard 62.6% of the time for adult diabetic patients, indicating that the tool was 
successful in changing provider behavior. Data analysis indicated that the Diabetes Wizard 
resulted in significantly improved Hb A1C and systolic blood pressure, but no significant change 
in LDL-C levels occurred compared to the control group. The physicians reported high 
satisfaction with the use of the tool.   
Methods 
 This study was conducted using a pre- and post-implementation design. A baseline 
review of 87 medical records was conducted to obtain a collective overall baseline adherence 
rate for the providers. Post-implementation data were collected to monitor adherence rates over 
the 8-week implementation period for each provider individually and collectively as group. Post- 
implementation data included adherence information from a total of 41 patient encounters. The 
providers received a survey at four-weeks post implementation to assess their satisfaction with 
the Diabetic LDL Protocol and office workflow.  
Study Setting and Sampling 
 The study was conducted in a family-owned primary care clinic that serves 
approximately 6400 patients in the Tualatin Valley of Oregon. The clinic offers comprehensive 
care to individuals and families at two locations; and services include routine care, physicals, 
vaccinations, respiratory care, back and neck pain, personal injury and worker’s compensation, 
diabetes care and education, healthy heart care, women’s health, and in-house x-ray and blood 
work. Providers include two doctors of osteopathic medicine (DOs), two family nurse 
practitioners (FNPs), one physician’s assistant (PA), and multiple medical assistants (MAs). 
Medical records of each patient 18 years or older with a hemoglobin A1C greater than 6% and an 
LDL-C level greater than 100 mg/dL who had had an office visit with a provider at the clinic 
within the 8-week implementation time frame were included in the data-collection process.  
Data Collection 
 Provider-specific data were collected to determine adherence rates for each individual 
primary care provider and then as a group. The following data were collected during the 
implementation period: frequency of use of the Diabetic LDL Protocol, percent of patients with 
current LDL-C levels (within the last year), percent of patients with a prescription for a lipid-
lowering medication, and percent of patients with appropriate ICD-9 or ICD-10 codes for 
hyperlipidemia accurately documented in the EHR problem list.  
Implementation Materials 
 An evidence-based electronic clinical decision support tool, the Diabetic LDL Protocol 
(see Figure 1) was designed and implemented into the EHR at the center. Providers were given 
copies of the office workflow diagram, which detailed when and how to use the Diabetic LDL 
Protocol in practice. The MAs were asked to scrub the chart of each patient being seen in the 
clinic at the start of the day, then to mark on the clinic’s visit summary sheet if the patient was a 
diabetic, 18 years or older with a hemoglobin A1C greater than 6% and LDL-C level greater than 
100 mg/dL. The provider was to then complete the Diabetic LDL Protocol during the clinical 
encounter. Patient education handouts on lifestyle and dietary modifications were given to the 
clinic for replication and distribution to patients. These documents served as a reminder for the 
providers to follow current evidence-based practice in the management and monitoring of LDL-
C values in diabetic patients.  
 
 
 
 
Procedures 
 This study was approved by the University of Portland (Oregon)’s institutional review 
board. Participation in the project was voluntary and all subjects signed an informed consent. 
Project authors signed confidentiality agreements at the clinic to ensure patient confidentially 
and protection of personal health information. All information collected was de-identified and 
anonymous.  
 Prior to their implementation of the Diabetic LDL Protocol, the clinic providers attended 
a 60-minute educational session. Information regarding the importance of LDL-C management 
in diabetics and the intent and use of the Diabetic LDL Protocol were discussed. The staff 
members were instructed on the workflow changes that would be necessary to implement the 
new protocol, and providers received education on lifestyle and dietary approaches to lowering 
lipid levels. Providers were also encouraged to ask questions and propose changes to the office 
workflow and Diabetic LDL Protocol. Emails, meetings, and a formal presentation were used to 
ensure that instructions were provided and expectations were established for implementation. A 
target LDL-C goal was agreed upon and set at less than 100mg/dL for patients with a 
hemoglobin A1c greater than 6%.  
 Data were collected from the EHR of patients who met inclusion criteria prior to 
implementation. The Diabetic LDL Protocol was then implemented over an eight-week period of 
time. After four weeks, six weeks, and eight weeks post-implementation, the EHR of eligible 
patients were reviewed.  
Data Analysis 
 Frequencies were used to determine differences between pre- and post-implementation 
rates of the percent of patients with current LDL-C levels (within the last year), percent of 
patients with a prescription for a lipid-lowering medication, and percent of patients with 
appropriate ICD-9 or ICD-10 codes for hyperlipidemia accurately documented in the EHR 
problem list. Provider adherence to use of the Diabetic LDL Protocol was assessed by 
determining frequency of use over the implementation period.  
Results 
Sample Characteristics  
 Eighty-seven medical records were reviewed prior to implementation. Among these 
patients, 47 (54%) had a LDL-C level documented within the last 12 months, 42 (48%) were 
prescribed a lipid-lowering medication, and 69 (79%) had an appropriate ICD- 9 code 
documented related to their elevated LDL-C level. Care was provided by five providers: two 
DOs, two NPs, one PA and their five MAs.  
Use of Diabetic LDL Protocol 
 At four weeks post-implementation, there had been 12 patient encounters that met the 
requirements for use of the Diabetic LDL Protocol; however, none of the providers had used the 
protocol during these encounters. Between weeks four and six, 20 patient encounters met the 
requirements for use of the Diabetic LDL Protocol and it was used during 11 (55%) of these 
patient encounters. Among these patients, 14 (70%) had a LDL-C level documented within the 
last 12 months, 12 (60%) were prescribed a lipid-lowering medication, and 16 (80%) had an 
appropriate ICD- 9 code documented related to their elevated LDL-C level. At eight weeks post-
implementation, there had been 9 additional patient encounters and the Diabetic LDL Protocol 
was used during only one (11%) of these patient encounters. Among these patients, 5 (56%) had 
a LDL-C level documented within the last 12 months, 8 (89%) were prescribed a lipid-lowering 
medication, and 9 (100%) had an appropriate ICD- 9 code documented related to their elevated 
LDL-C level.  
 At eight weeks post-implementation, a total of 41 patient encounters had met the 
requirements for use of the Diabetic LDL Protocol, and the protocol was used during 12 (29%) 
of them. Among these 41 patients, 28 (68%) had a LDL-C level documented within the last 12 
months, 27 (66%) were prescribed a lipid-lowering medication, and 35 (85%) had an appropriate 
ICD- 9 code documented related to their elevated LDL-C level (see Table 1).    
Table 1 
  
Pre- and Post-Implementation Results of Outcome Measures  
 
Category Frequency Percent 
Pre-implementation (n= 87) 
     LDL-Ca <12 months 
     Medication 
     ICD-9b  
 
47 
42 
69 
 
54 
48 
79 
Post-implementation (4 weeks; n= 12)  
     Protocol used 
     LDL-C <12 months 
     Medication 
     ICD-9 
 
0 
9 
7 
10 
 
0 
75 
58 
83 
Post-implementation (6 weeks; n=20)  
     Protocol used 
     LDL-C <12 months 
     Medication 
     ICD-9 
 
11 
14 
12 
16 
 
55 
70 
60 
80 
Post-implementation (8 weeks; n=9)  
     Protocol used 
     LDL-C <12 months 
     Medication 
     ICD-9 
 
1 
5 
8 
9 
 
11 
56 
89 
100 
 
aLDL-C =  low-density lipoprotein cholesterol 
bICD-9  =  international classification of diseases, 9th rev.  
 
 
 
Processes of Implementation  
 Providers were given a survey at four weeks post-implementation to assess their 
satisfaction with the pre-implementation education regarding the purpose of the Diabetic LDL 
Protocol and clinic workflow as well as ease of use and value in caring for diabetic patients. 
Providers were asked to rate their satisfaction on a Likert scale ranging from 1 (very dissatisfied) 
to 5 (very satisfied). Open-ended questions were asked so providers could offer feedback and 
suggest changes moving forward. Surveys were given to the five primary care providers and 
their five MAs as well as the RN care manager; 64% of the surveys were returned, all 
anonymously.  
 Of the respondents, 57% indicated they were satisfied with the 60-minute education 
session given prior to implementation; the remaining 43% of respondents did not attend the 
education session. Providers expressed that they found education regarding the importance of 
managing LDL-C values in diabetics beneficial. One provider wanted coaching on interacting 
with patients regarding LDL-C values. Providers were either satisfied (43%) or neutral (43%) 
regarding office workflow. Feedback included increasing communication in the clinic and more 
involvement from the MAs in checking LDL-C values. Of the providers, 29% found the Diabetic 
LDL Protocol valuable in caring for diabetic patients, the other 71% were indifferent. Providers 
thought the Diabetic LDL Protocol reminded them to use statins in diabetics, order lipid panels if 
the last LDL-C value was more than 12 months earlier, and that the overall goal of the protocol 
was to improve the health of patients.   
 
 
 
Discussion 
 There were no significant increases in LDL-C monitoring, medication management, or 
ICD-9 documentation in the post-implementation phase. The data reflect overall trends in LDL-
C documentation, prescribing of medications, and ICD-9 code documentation for the patients 
during the implementation period. Since the providers may have already met these requirements 
prior to the encounter during the study, the values do not necessarily indicate that the use of the 
protocol led to changes in provider behavior.  However, use of the protocol may be associated 
with improved LDL-C management.  
 Use of the Diabetic LDL Protocol peaked at 6 weeks and steadily declined by 8 weeks. 
These findings are consistent with previous studies, which have shown that merely using 
electronic alerts in the EHR does not improve patient outcomes; changes are best made when 
clinical support tools encourage a provider to implement the appropriate intervention (Sperl-
Hillen et al., 2010).   
 Results of this study demonstrate that electronic alerts and inferior clinical support tools 
do not overcome clinical inertia in the management of LDL-C values in diabetics. Providers at 
the clinic were not providing care consistent with national guidelines targeting LDL-C values in 
diabetics both prior to and after the implementation as evidenced by failure to use the Diabetic 
LDL Protocol and to more aggressively treat elevated LDL-C values.  
 An important factor to consider when determining the potential impact of the electronic 
tool on patient outcomes is the capability of the clinic’s EHR system. Due to restrictions within 
the EHR system at this clinic, the staff were unable to fully create an electronic version of the 
Diabetic LDL Protocol as initially designed by the project authors. The clinic was only able to 
create a tool that asked providers if a patient’s LDL-C was greater than 100 mg/dL and, if so, to 
ask if an educational handout on diet was given and if the patient was on statins. They were 
unable to create an algorithm that could incorporate ordering of lab values, making medication 
adjustments, documenting the appropriate ICD-9 code, and recommending appropriate follow-
up. Since the design of the protocol was adjusted to fit the clinic’s EHR capabilities and was not 
fully used as intended, improved compliance with the Diabetic LDL Protocol may not 
necessarily result in improved patient outcomes overtime. 
 Previous studies have demonstrated that the success to implementing practice change lies 
in clear communication about the purpose and process of the implementation as well as early 
buy-in from medical staff (O’Connor et al., 2011; Sperl-Hillen et al., 2010). The results of this 
study reinforce the importance of frequently communicating the purpose and process of the 
intervention both pre- and post-implementation. Thus, the lack of provider adherence and use of 
the Diabetic LDL Protocol, and a more aggressive management of LDL-C values may be 
contributed to insufficient communication regarding the purpose and process of implementation 
as evidenced by one provider stating he or she was unaware of the protocol four weeks post-
implementation. Furthermore, post-implementation communication was mainly focused on the 
primary care providers and not the MAs, which is likely to have impacted adherence rates due to 
increased burden of responsibility on the primary care providers.  
Limitations 
 The limitations of this study must be considered when assessing its implications to the 
care of patients with diabetes. First, the study was limited to a small family-owned primary care 
clinic in the Tualatin Valley of Oregon, which may differ from other care settings and 
geographical locations. As previously mentioned, the protocol was not implemented as initially 
designed. Due to constraints within the EHR, the clinic’s informatics department created an 
alternative version of the evidence-based protocol. These changes likely impacted the quality of 
the electronic tool. 
 The small sample size is an additional limitation. Only five primary care providers 
practiced within the clinic during the study, and they saw a total of 41 patients who met inclusion 
criteria for EHR review. The small sample size and short duration of the study pose the questions 
of whether the Diabetic LDL Protocol will be used in the long term. Furthermore, the short 
duration of the study was such that patient outcomes were not tracked. It is unknown if use of the 
Diabetic LDL Protocol will affect changes in patient outcomes at this clinic.  
Implications  
Implications for Practice 
 The findings of this study are relevant to primary care clinical practice. Findings indicate 
that the use of health management tools in the EHR helps providers adhere to evidence-based 
recommendations regarding LDL-C management in diabetics. Unfortunately, the EHR at the 
clinic was unable to fully support the Diabetic LDL Protocol in its entirety, likely decreasing its 
ability to effect changes in patients’ LDL-C values. In order for clinics to fully comply with 
reporting and demonstrating meaningful use of the EHR in order to receive reimbursement under 
the Medicare and Medicaid Electronic Health Record Incentive Program (Centers for Medicare 
and Medicaid Services, 2014), EHRs need to be able to support health management tools and 
algorithms designed to increase provider compliance with evidence-based practice. Furthermore, 
use of health management tools embedded in the EHR should be accompanied by periodic chart 
audits to determine adherence with practice recommendations and to monitor changes in patient 
outcomes. Data collection, even with an EHR, can be a tedious process. By embedding health 
management tools into the EHR in a way that automatically collects, analyzes, and provides a 
breakdown of data can benefit a clinic’s ability to track provider compliance and patient 
outcomes (Umar-Kamara & Tufts, 2013).  
Implications for Research 
 Findings from this study have implications for future research. Longer studies should be 
conducted across different primary care settings and with control groups to determine provider 
acceptance and compliance with electronic Diabetic LDL-C support tools such as the Diabetic 
LDL Protocol, and to track patient outcomes. Results from future studies can help determine how 
to best use EHRs to improve the quality of care provided to diabetics with elevated LDL-C 
levels.  
Conclusion 
 This clinic will not likely experience an improvement in patient outcomes without more 
aggressive medical and lifestyle management for its diabetic population. Considering the EHR 
limitations and the communication issues regarding the new protocol, practice change seems 
unlikely under the current conditions. Further attempts to change practice at this clinic will 
require updates to the EHR system that will enhance ease of use and will incorporate all the 
necessary components of LDL-C management. Improved communication methods and 
additional support and training will be necessary to increase provider buy-in to inspire practice 
change and promote sustainability.   
 
  
Diabetic LDL Protocol  
 
 
**** Patient Information **** 
 
 Value       Date   Goal 
LDL-Ca      xxmg/dL/ or none on file  00/00/00  <100mg/dL  
 
 
Current LDL-C lowering medication:  
XYZ or none on file 
 
 
Does patient have a current LDL-C value (within the past 12-months?) 
 
 - No:  order fasting lipid panel 
 - Yes:  is LDL-C greater than 100mg/dL?  
  - No: no changes to therapy 
  - Yes: consider lifestyle modifications and/or medication 
 
 
**** Treatments to Consider **** 
 
* Lifestyle modifications  
 - Diet: TLCb, portfolio, Mediterranean diet  
 - Exercise, smoking cessation, limit alcohol consumption, weight management 
 
* Consider ordering/increasing lipid-lowering medication with lifestyle modifications 
 
 
**** Follow-Up **** 
 
Consider follow-up visits every 8 weeks until better LDL-C control is achieved! 
 
 
How was LDL-C treatment modified? 
 
- Lifestyle modification 
- Lifestyle modification AND medication 
- Medication 
- No treatment given (why) 
 
 
Figure 1.  Diabetic LDL protocol.  
aLDL-C =  low-density lipoprotein cholesterol 
bTLC  =   therapeutic lifestyle changes  
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